Market Cap

Biosino Bio-Technology and Science InCorp Market Capitalization:

HK$127.3 Million

HKD as of Jan. 1, 2024

US$16.3 Million

business Biosino Bio-Technology and Science InCorp Company Profile

Biosino Bio-Technology and Science InCorp Main Stock Listing

HKEX: 8247

Market Capitalization History of Biosino Bio-Technology and Science InCorp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Biosino Bio-Technology and Science InCorp market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$127.3 M -31.25%
Jan. 1, 2023 HK$185.2 M -32.28%
Jan. 1, 2022 HK$273.5 M -7.80%
Jan. 1, 2020 HK$296.6 M 33.12%
Jan. 1, 2019 HK$222.8 M -28.70%
Jan. 1, 2018 HK$312.6 M -12.55%
Jan. 1, 2017 HK$357.4 M -26.92%
Jan. 1, 2016 HK$489.1 M 39.09%
Jan. 1, 2015 HK$351.6 M -29.97%
Jan. 1, 2014 HK$502.1 M 89.62%
Jan. 1, 2013 HK$264.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Biosino Bio-Technology and Science InCorp Categories

China languages Healthcare languages Diagnostics & Research
China Healthcare China Diagnostics & Research

Stocks & Indices

Biosino Bio-Technology and Science InCorp has the following listings and related stock indices.


Stock: HKEX: 8247

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.